HIGHLIGHTS
- who: Zihao Li from the Department of Neurology of Nanjing Drum Tower Hospital, Medical School and the State Key Laboratory of Pharmaceutical Biotechnology, Translational Medicine Institute of Brain Disorders, Nanjing University, Nanjing, China, Institute of Brain have published the paper: The Regulation and Modification of GSDMD Signaling in Diseases, in the Journal: (JOURNAL)
SUMMARY
Subsequently, with the disruption of plasma_membrane integrity, tremendous inflammatory factors, such as Interleukin-1b (IL-1b), Interleukin-18 (IL-18), and tumor necrosis Frontiers in Immunology | www.frontiersin.org June 2022 | Volume 13 | Article 893912 Regulation and Modification of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.